Anti-Human HLA A2,B7 (MHC Class I) In Vivo Antibody - Ultra Low Endotoxin
- SKU:
- IVMB0355
- Product Type:
- In Vivo Monoclonal Antibody
- Clone:
- BB7.6
- Protein:
- HLA-A2,B7 ⋅ MHC Class I
- Isotype:
- IgG1
- Reactivity:
- Human
- Synonyms:
- HLA-A
- Synonyms:
- HLA-A2,B7
- Synonyms:
- B.C.HLA-A2
- Research Area:
- Immunology
- Endotoxin Level:
- Ultra Low Endotoxin
- Host Species:
- Mouse
- Applications:
- FC
- Applications:
- In Vivo
Description
| Product Name: | Anti-Human HLA A2,B7 (MHC Class I) In Vivo Antibody - Ultra Low Endotoxin |
| Product Code: | IVMB0355 |
| Size: | 1 mg, 5 mg, 25 mg, 50 mg, 100 mg |
| Clone: | BB7.6 |
| Protein: | HLA-A2,B7 ⋅ MHC Class I |
| Product Type: | Monoclonal Antibody |
| Synonyms: | HLA-A, HLA-A2,B7, B.C.HLA-A2 |
| Isotype: | IgG1 |
| Reactivity: | Human |
| Applications: | FC, In Vivo |
| Formulation: | This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. |
| Endotoxin Level: | <0.5 EU/mg as determined by the LAL method |
| Purity: | ≥98% monomer by analytical SEC ⋅ >95% by SDS Page |
| Product Preparation: | Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. |
| Applications: | FC, In Vivo |
| Reactivity: | Human |
| Host Species: | Mouse |
| Specificity: | Clone BB7.6 recognizes an epitope shared by the human MHC class I molecule HLA-B. |
| Antigen Distribution: | HLA-B is ubiquitously expressed on nucleated cells. |
| Immunogen: | Solubilized HLA-B7 antigen |
| Concentration: | ≥ 5.0 mg/ml |
| Endotoxin Level: | <0.5 EU/mg as determined by the LAL method |
| Formulation: | This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. |
| Purity: | ≥98% monomer by analytical SEC ⋅ >95% by SDS Page |
| Preparation: | Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. |
| Storage and Handling: | Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles. |
| Protein: | HLA-A2,B7 ⋅ MHC Class I |
| Research Area: | Immunology |
| Pathogen Testing: | To protect mouse colonies from infection by pathogens and to assure that experimental preclinical data is not affected by such pathogens, all of Assay Genie's Purified Functional Antibodies are tested and guaranteed to be negative for all pathogens in the IDEXX IMPACT I Mouse Profile. |
| Shipping: | 2-8°C |
Related Products
Anti-Human HLA A2,B7 (MHC Class I) In Vivo Antibody - Low Endotoxin
Anti-Human HLA-A, B, C (MHC Class I) In Vivo Antibody - Ultra Low Endotoxin
Anti-Human HLA-DQ (MHC Class II) In Vivo Antibody - Ultra Low Endotoxin
Anti-Human HLA-DR (MHC Class II) In Vivo Antibody - Ultra Low Endotoxin
